Medical Weight Loss for Lafayette, Louisiana Residents

Lafayette, Louisiana residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Lafayette through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Start this week from Lafayette: book a video visit, complete your intake, and if you are a fit, your compounded medication ships to your Louisiana door. No travel to California required. Doctor review just $119 (medication separate).

Why Lafayette Residents Choose New Hope Weight Loss

For Lafayette patients who want a doctor genuinely involved, this is the right fit. Compounded semaglutide and tirzepatide are powerful tools, but they are not for everyone, and Dr. Anjmun Sharma treats them that way. She looks at your labs, your medications, and your goals before anything is prescribed, then keeps adjusting as your body responds. These medications are not FDA-approved and results vary, which is exactly why physician oversight matters this much.

Medical weight loss for Lafayette is handled end-to-end online: intake, the $119 physician review with Dr. Sharma, dose titration, and follow-ups, all by secure video, with no drive and no pharmacy line.

Patients in Lafayette get the identical physician-supervised treatment that someone walking into our Costa Mesa office would get, all of it handled by telehealth so Louisiana residents never have to travel. We care for patients throughout Downtown and the greater Acadiana region. Your plan is shaped around your own history, the medications you have tried, and the goals you bring, not a one-size template applied to every Lafayette patient.

By handling visits through telehealth, we serve every neighborhood in Lafayette, from Downtown and the greater Acadiana region, without asking anyone to travel. There is no distance surcharge for Lafayette, so you pay the same $119 review fee whether you live near the Downtown and the greater Acadiana region area or anywhere else in Louisiana. From one end of Louisiana to the other, New Hope Weight Loss provides physician-supervised GLP-1 care by telehealth from our Costa Mesa, California clinic, with no need to visit in person.

GLP-1 Weight Loss Programs Available

Semaglutide 90-Day Metabolic Reset, from $166/mo

Most Lafayette patients start here. Semaglutide shares its active ingredient with Wegovy and Ozempic, and in branded-drug trials people lost an average of 15 to 17 percent of body weight. Our program runs $499 for 90 days, with Dr. Sharma adjusting your dose each month by telehealth. Results vary, and compounded semaglutide is not FDA-approved or brand-identical.

Tirzepatide, from $233/mo

Tirzepatide works on two hunger pathways at once, GLP-1 and GIP. In trials of the branded drug, qualified patients reached up to 22.5 percent body-weight loss, which is a high-dose figure and not typical. It shares its active ingredient with Mounjaro and Zepbound.

$119 physician review. Medication is billed separately. We accept HSA, FSA, Klarna, and Affirm, with no surcharge for treating you in Lafayette by telehealth.

How Telehealth Works for Lafayette

Step 1 of 4: Answer the intake quiz online, sharing your weight history, current health, and what you hope to reach.

Step 2 of 4: Dr. Sharma reviews your responses and connects by secure video, usually within 48 hours, to confirm whether compounded semaglutide or tirzepatide is a reasonable option for you.

Step 3 of 4: A state-licensed 503(a) pharmacy ships your prescription to your Lafayette address in insulated cold-pack packaging.

Step 4 of 4: Follow-up visits run by video, so you and Dr. Sharma adjust as needed without travel anywhere in .

Frequently Asked Questions, Lafayette

Is there somewhere in Lafayette I can visit New Hope Weight Loss?

There is no physical office in Lafayette. We work from a single clinic in Costa Mesa, California, and care for Lafayette, Louisiana patients by telehealth. Your candidacy for a compounded GLP-1 plan is confirmed when Dr. Anjmun Sharma reviews your health information during an online video appointment.

Will Lafayette patients have to make any in-person trips?

No trips are necessary. We provide care to Lafayette completely through telehealth, covering consults, follow-up visits, and ongoing support remotely. Once Dr. Sharma signs off, your compounded semaglutide or tirzepatide is delivered to Lafayette in cold-pack shipping that preserves the correct temperature.

What does the program cost a Lafayette patient?

Budget $119 for the physician visit. Semaglutide is priced from $166 monthly or $499 for 90 days, and tirzepatide from $233 monthly. The medication is a separate line item. We accept HSA, FSA, Klarna, and Affirm, and no distance surcharge is added for patients located in Lafayette.

What areas of Lafayette do you serve?

We serve patients from across Lafayette by telehealth, including Downtown and the greater Acadiana region.

Is my health information private as a Lafayette patient?

Yes. Your intake, video visits, and records are handled under HIPAA safeguards, and medication arrives in discreet packaging. Lafayette patients get the same confidentiality as any telehealth patient.

Lafayette Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Lafayette, Louisiana by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.